|
881 |
Comparative analysis of three platforms for serum NfL quantification in healthy controls and MS patients
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 4: 880-888. 09 S.
|
|
|
|
882 |
At-home blood collection for clinical chemistry analyses in a kidney transplant population: a feasibility study
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 4: 855-865. 11 S.
|
|
|
|
883 |
Assessment of drone transport for biological samples: a real-world experience at a tertiary hospital
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 4: 821-831. 11 S.
|
|
|
|
884 |
Recommendations from the IFCC Working Group on Laboratory Errors and Patient Safety for the Global Adoption of an Essential Quality Indicators Panel in Laboratory Medicine
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 4: 806-812. 07 S.
|
|
|
|
885 |
Prognostic utility of serial procalcitonin measurements in ICU sepsis: a laboratory-led modelling approach in a resource-limited setting procalcitonin modelling for sepsis mortality in a low-resource ICU
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 3: 741-747. 07 S.
|
|
|
|
886 |
Spot urine is a suitable matrix for measurement of copeptin
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 3: 662-669. 08 S.
|
|
|
|
887 |
Short- and medium-term pre-analytical stability of human serum insulin-like growth factor-1
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 3: 630-639. 10 S.
|
|
|
|
888 |
Small-scale external quality assessment of methylated SHOX2 and RASSF1A detection in China: findings from 2023–2024
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 3: 609-616. 08 S.
|
|
|
|
889 |
Optimization and comparison of genomic DNA extraction from whole blood collected in PAXgene blood RNA tube using automated platforms
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 3: 600-608. 09 S.
|
|
|
|
890 |
Methodological evaluation and clinical interpretation of hs-cTnI and hs-cTnT variations: a reappraisal
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 3: 566-569. 04 S.
|
|
Administration
